Our Peer-Reviewed Publications

MC-RWE>Publication Assistance>Our Peer-Reviewed Publications

Our Peer-Reviewed Publications

    • Poster presented at the European Society of Cardiology Congress 2019; 31 Aug – 4 Sep 2019, Paris, France.
      Renal and cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: a systematic review and meta-analysis. Burnier M, Ruilope L, Bader G, Durg S, Brunel P. European Heart Journal. 2019 Oct 21;40(suppl_1):ehz748.0962
      https://doi.org/10.1093/eurheartj/ehz748.0962
 
    • Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis. Burnier M, Lin S, Ruilope L, Bader G, Durg S, Brunel P. Blood pressure. 2019 Dec;28(6):358-374. https://doi.org/10.1080/08037051.2019.1644155
   
    • A systematic review and meta-analysis of oxaceprol in the management of osteoarthritis: An evidence from randomized parallel-group controlled trials.
      Durg S, Lobo M, Venkatachalam L, Rao G, Bhate J. Pharmacological Reports. April 2019; 71 (2):374-383 https://doi.org/10.1016/j.pharep.2018.12.010
 
    • Poster presented at 27th Scientific Meeting of the International Society of Hypertension, 20–23 September 2018, Beijing, China.
      Renoprotective effect of angiotensin receptor blockers beyond their BP lowering effect in patients with hypertension and chronic kidney disease: A systematic review and meta-analysis Burnier M, Ruilope L, Lin S, Bader G, Durg S, Lin D, Brunel P. Journal of Hypertension. October 2018;36;e127 https://doi.org/10.1097/01.hjh.0000548509.61874.fc
 
    • Poster presented at the European Society of Cardiology Congress 2018; 25–29 August, 2018; Munich, Germany.
      Cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: a systematic review and meta-analysis. Burnier M, Lin S, Ruilope L, Bader G, Durg S, Lin D, Brunel P. European Heart Journal. 2018 Aug 1;39(suppl_1):ehy563-P3206 https://doi.org/10.1093/eurheartj/ehy563.P3206
 
    • LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: A systematic review and meta-analysis. Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K. https://doi.org/10.2147/COPD.S130482